Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Eisenreich, DE
Andreas Eisenreich, Beilstein DE
| Patent application number | Description | Published |
|---|---|---|
| 20120125230 | Formwork Release Composition And Use Thereof - A formwork release composition containing formwork release oil, which contains a hydrophobic metal oxide and/or metal sulphide component is disclosed. Photocatalytically active compounds, such as particular semiconductors and in particular TiO | 05-24-2012 |
Katrin Eisenreich, Dresden DE
| Patent application number | Description | Published |
|---|---|---|
| 20120066194 | APPROXIMATE REPRESENTATION AND PROCESSING OF ARBITRARY CORRELATION STRUCTURES FOR CORRELATION HANDLING IN DATABASES - Implementations of the present disclosure include receiving user input, the user input indicating a distribution type and a correlation factor, providing the distribution type and correlation factor for identifying an approximate correlation representation (ACR) histogram from a plurality of ACR histograms based on the distribution type and the correlation factor, receiving the ACR histogram, retrieving a first distribution associated with a first uncertain value and a second distribution associated with a second uncertain value from computer-readable memory, processing the ACR histogram, the first distribution and the second distribution to generate a correlation histogram that represents a correlation between the first uncertain value and the second uncertain value, and displaying the correlation histogram on a display. | 03-15-2012 |
Wolfgang Eisenreich, Garching DE
| Patent application number | Description | Published |
|---|---|---|
| 20090199313 | Non-mevalonate isoprenoid pathway - The present invention is directed to enzymes and intermediates of the non-mevalonate isoprenoid pathway downstream of 2C-methyl-D-erythritol 2,4-cyclopyrophosphate and upstream of isopentenyl pyrophosphate or dimethylallyl pyrophosphate. These are used as a basis for a screening method for inhibitors of these enzymes, and a method for identifying inhibitor-resistant variants thereof. Further disclosures refer to DNA coding for said enzymes and for inhibitor-resistant variants thereof, vectors containing said DNA, cells containing said vector, and plant seeds comprising cells containing said vector. This invention is useful for the inhibition of the biosynthesis of isoprenoids in plants, bacteria and protozoa, for conferring herbicide-resistance to plants, as well as for weed control in agriculture using a crop containing a herbicide-resistant gene and an effective amount of a suitable herbicide. | 08-06-2009 |
Wolfgang Eisenreich, Freising DE
| Patent application number | Description | Published |
|---|---|---|
| 20080318227 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway - The invention provides a protein in a form that is functional for the enzymatic conversion of 2C-methyl-D-erythritol 2,4-cyclodiphosphate to 1-hydroxy-2-methyl-2-butenyl 4-diphosphate notably in its (E)-form of the non-mevalonate biosynthetic pathway to isoprenoids. The invention also provides a protein in a form that is functional for the enzymatic conversion of 1-hydroxy-2-methyl-2-butenyl 4-diphosphate, notably in its (E)-form, to isopentenyl diphosphate and/or dimethylallyl diphosphate. Further, screening methods for inhibitors of these proteins are provided. Further, 1-hydroxy-2-methyl-2-butenyl 4-diphosphate is provided and chemical and enzymatic methods of its preparation. | 12-25-2008 |
Wolfram Eisenreich, Ulm DE
| Patent application number | Description | Published |
|---|---|---|
| 20090041844 | Modified Release Formulation - The invention is directed to the use of an extended release tablet formulation for pramipexole. | 02-12-2009 |
| 20090098202 | Extended Release Formulation - The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof. | 04-16-2009 |
| 20090281153 | Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof - An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch. | 11-12-2009 |
| 20100209506 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to pharmaceutical compositions of linagliptin, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders. | 08-19-2010 |
| 20110014284 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders. | 01-20-2011 |
| 20110150994 | Modified Release Formulation - The invention is directed to the use of an extended release tablet formulation for pramipexole. | 06-23-2011 |
| 20110195122 | Extended Release Formulation - The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof. | 08-11-2011 |
| 20110236477 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a SGLT-2 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases. | 09-29-2011 |